Stem cell enriched, T cell depleted haplocompatible peripheral blood transplantation for children with myelodysplastic disease, leukemia, marrow failure syndromes, or severe immunodeficiency diseases.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antithymocyte globulin (Primary) ; Fludarabine (Primary) ; Thiotepa (Primary)
- Indications Aplastic anaemia; Graft-versus-host disease; Immunological disorders; Leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 12 Nov 2012 Biomarkers information updated
- 01 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Dec 2009 Actual initiation date (Apr 2005) added as reported by ClinicalTrials.gov.